These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 235218)

  • 21. Sodium and angiotensin in the pathogenesis of experimental renovascular hypertension.
    Seymour AA; Davis JO; Freeman RH; DeForrest JM; Rowe BP; Stephens GA; Williams GM
    Am J Physiol; 1981 May; 240(5):H788-92. PubMed ID: 6263111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of angiotensin antagonists in various forms of experimental arterial hypertension.
    Ferrario CM; Bumpus FM; Masaki Z; Khosla MC; McCubbin JW
    Prog Biochem Pharmacol; 1976; 12():86-97. PubMed ID: 1019172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin and renovascular hypertension.
    Lancet; 1970 Feb; 1(7642):342-3. PubMed ID: 4189589
    [No Abstract]   [Full Text] [Related]  

  • 24. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma vasopressin in blood pressure homeostasis and in experimental renal hypertension.
    Pullan PT; Johnston CI; Anderson WP; Korner PI
    Am J Physiol; 1980 Jul; 239(1):H81-7. PubMed ID: 7396022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is the peripheral sympatho-adrenal nervous system necessary for renal hypertension?
    Douglas JR; Johnson EM; Heist JF; Marshall GR; Needleman P
    J Pharmacol Exp Ther; 1976 Jan; 196(1):35-43. PubMed ID: 1246014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute renovascular hypertension in conscious dogs. Interaction of the renin-angiotensin system and sympathetic nervous system in systemic hemodynamics and regional blood flow responses.
    Gavras H; Liang C
    Circ Res; 1980 Sep; 47(3):356-65. PubMed ID: 6157500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms involved in two-kidney renal hypertension induced by constriction of one renal artery.
    Freeman RH; Davis JO; Watkins BE; Lohmeier TE
    Circ Res; 1977 May; 40(5 Suppl 1):I29-35. PubMed ID: 870229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in plasma and cerebrospinal fluid norepinephrine and angiotensin II during the development of renal hypertension in conscious dogs.
    Suzuki H; Ferrario CM; Speth RC; Brosnihan KB; Smeby RR; de Silva P
    Hypertension; 1983; 5(2 Pt 2):I139-48. PubMed ID: 6337956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and pathophysiological changes in chronic two-kidney hypertension in the dog.
    Watkins BE; Davis JO; Hanson RC; Lohmeier TE; Freeman RH
    Am J Physiol; 1976 Sep; 231(3):954-60. PubMed ID: 970479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP.
    Fujino T; Nakagawa N; Yuhki K; Hara A; Yamada T; Takayama K; Kuriyama S; Hosoki Y; Takahata O; Taniguchi T; Fukuzawa J; Hasebe N; Kikuchi K; Narumiya S; Ushikubi F
    J Clin Invest; 2004 Sep; 114(6):805-12. PubMed ID: 15372104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II blockade and the functions of the renin-angiotensin system.
    Davis JO; Freeman RH; Watkins BE; Stephens GA; Williams GM
    Prog Biochem Pharmacol; 1976; 12():1-15. PubMed ID: 798202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute renal haemodynamic and renin-angiotensin system responses to graded renal artery stenosis in the dog.
    Anderson WP; Johnston CI; Korner PI
    J Physiol; 1979 Feb; 287():231-45. PubMed ID: 219182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal hypertension following aortic constriction is abolished by angiotensin II converting enzyme inhibitor, but not by low-salt diet.
    Eklöf AC; Aperia A
    Acta Physiol Scand; 1990 Jul; 139(3):435-40. PubMed ID: 2239346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin converting enzyme inhibition improves diagnostic procedures for renovascular hypertension in dogs.
    Jonker GJ; de Zeeuw D; Huisman RM; Piers DB; Beekhuis H; van der Hem GK
    Hypertension; 1988 Oct; 12(4):411-9. PubMed ID: 3169950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Goldblatt memorial lecture. Part I: Experimental renovascular hyptertension.
    Barger AC
    Hypertension; 1979; 1(5):447-55. PubMed ID: 396244
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenic factors involved in renovascular hypertension. State of the art.
    Bumpus FM; Khosla MC
    Mayo Clin Proc; 1977 Jul; 52(7):417-23. PubMed ID: 327161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The course of arterial pressure and the effect of Sar1-Thr8-angiotensin II in a new model of two-kidney hypertension in conscious dogs.
    Masaki Z; Ferrario CM; Bumpus FM; Bravo EL; Khosla MC
    Clin Sci Mol Med; 1977 Feb; 52(2):163-70. PubMed ID: 844249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the renin-system in normo- and hypertension. Effect of angiotensin-inhibitor (1-sar-8-ala-angiotensin II) on the blood pressure of conscious or anaesthetized normal, nephrectomized and renal hypertensive rats.
    Bing J; Nielsen K
    Acta Pathol Microbiol Scand A; 1973 May; 81(3):254-62. PubMed ID: 4358386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.